首页 > 市场调查报告书 > 製药

疼痛

市场调查报告书

商品编码

1461338

医用大麻市场，按产品类型、按化合物、按应用、按分销管道、按地区

Medicinal Cannabis Market, By Product Type, By Compound (Tetrahydrocannabinol and Cannabidiol ), By Application, By Distribution Channel, By Geography .

出版日期: 2024年03月08日 | 出版商:

Coherent Market Insights | 英文 171 Pages | 商品交期: 2-3个工作天内

价格

简介目录

医用大麻市场预计2024年为194.4亿美元，预计2031年将达到822.7亿美元，2024年至2031年年复合成长率（CAGR）为22.9%，预计还会成长。

报告范围		报告详情
基准年	2023年	2023/2024年市场规模	194.4亿美元
实际资料	2019-2023	预测期	2024-2031
预测期2023/2024-2030/2031复合年增长率	22.90%	2030/2031 年预测值	822.7亿美元

2024 年按地区分類的医用大麻市场占有率(%)

医用大麻又称医用大麻，是指利用整个、未经加工的大麻植物或其基本萃取物来治疗疾病或改善症状。大麻含有多种精神活性化合物，可以缓解癌症、阿兹海默症、帕金森氏症、癫痫、慢性疼痛等患者的疼痛、噁心、焦虑和其他症状。美国以及欧洲和拉丁美洲各国等主要市场的医用大麻日益合法化，预计将在未来几年推动对大麻药物和保健产品的需求。此外，积极的临床试验研究探索各种大麻素的药用特性可能会推动全球医用大麻的采用。

市场动态：

全球医用大麻市场的推动因素包括各国医用大麻日益合法化、患有慢性疼痛和其他医疗用途的患者数量不断增加、公众对大麻治疗作用的认识不断提高以及对大麻素药物製剂的需求不断增加。和开发的进展是一个主要因素。然而，社会接受度、严格监管和有限的大麻分销管道等挑战仍然是市场快速成长的障碍。在新兴经济体扩大医用大麻的使用范围、推出创新的输送方法、开发具有医疗功效的合成大麻素药物以及将大麻萃取物融入营养补充和机能性食品中存在机会。

本研究的主要特点

该报告对全球医用大麻市场进行了详细分析，并提供了以2023年为基准年的预测期（2024-2031）的市场规模和年复合成长率（CAGR%）。
它还强调了各个细分市场的潜在收益成长机会，并说明了该市场有吸引力的投资提案矩阵。
它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要见解。
它根据公司亮点、产品系列、主要亮点、财务表现和策略等参数，介绍了全球医用大麻市场的主要企业。
该报告的见解预计将使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
全球医用大麻市场报告迎合了该行业的各种相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
相关人员可以透过分析全球医用大麻市场时所使用的各种策略矩阵来促进决策。

BOL Pharma
最新动态/更新
Tilray
Medreleaf Corporation
Aurora Cannabis Inc.
Canopy Growth Corporation
Insys Therapeutics Inc.
Aphria Inc.
MGC Pharmaceuticals Limited
GW Pharmaceuticals plc.
Medical Marijuana Inc
Enveric Biosciences
Pascal Biosciences
Realize Therapeutics
Celadon Pharmaceuticals Plc.
MAK Scientific LLC
MIRA Pharmaceuticals
Cardiol Therapeutics

第11章盛衰

繁荣与衰落
综合机会图

第十二章参考文献与调查方法

参考
调查方法

简介目录

Product Code: CMI40

The medicinal cannabis market is estimated to be valued at USD 19.44 Bn in 2024 and is expected to reach USD 82.27 Bn by 2031, growing at a compound annual growth rate (CAGR) of 22.9% from 2024 to 2031.

Report Coverage		Report Details
Base Year:	2023	Market Size in 2023/2024:	US$ 19.44 Bn
Historical Data for:	2019 to 2023	Forecast Period:	2024 to 2031
Forecast Period 2023/2024 to 2030/2031 CAGR:	22.90%	2030/2031 Value Projection:	US$ 82.27 Bn

Medicinal Cannabis Market Share (%), By Region, 2024

Medicinal cannabis, also known as medical marijuana, refers to using the whole unprocessed marijuana plant or its basic extracts to treat diseases or improve symptoms. It contains several mind-altering chemical compounds that can relieve pain, nausea, anxiety, and other symptoms in patients with conditions including cancer, Alzheimer's, Parkinson's, epilepsy, and chronic pain. The increasing legalization of medicinal cannabis in major markets like the U.S. and various countries in Europe and Latin America is expected to boost the demand for cannabis-based pharmaceutical and wellness products over the coming years. Moreover, active research in clinical trials to explore the medicinal benefits of various cannabinoids is likely to propel the adoption of medicinal cannabis globally.

Market Dynamics:

The global medicinal cannabis market is primarily driven by the rising legalization of cannabis for medical use across countries, growing patient pool for chronic pain, and other medical applications, increasing public awareness about the therapeutic benefits of cannabis, and ongoing research & development for cannabinoid-based pharmaceutical formulations. However, challenges around social acceptance, strict regulations, and limitations on cannabis distribution channels remain barriers to rapid market growth. Opportunities exist in expanding access to medical cannabis in emerging economies, launching innovative delivery methods, developing synthetic cannabinoid drugs with medical advantages, and integrating cannabis extracts into nutraceuticals and functional foods.

Key Features of the Study:

This report provides an in-depth analysis of the global medicinal cannabis market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global medicinal cannabis market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study BOL Pharma, Tilray, Medreleaf Corporation, Aurora Cannabis Inc., Canopy Growth Corporation, Insys Therapeutics Inc., Aphria Inc., MGC Pharmaceuticals Limited, GW Pharmaceuticals plc., Medical Marijuana Inc, Enveric Biosciences, Pascal Biosciences, Realize Therapeutics, Celadon Pharmaceuticals Plc., MAK Scientific LLC, MIRA Pharmaceuticals, and Cardiol Therapeutics.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global medicinal cannabis market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global medicinal cannabis market

Market Segmentation

Product Type:
- Flower
- Concentrates
- Edibles
- Topicals & Transdermals
- Others
Compound:
- Tetrahydrocannabinol (THC)
- Cannabidiol (CBD)
Application:
- Cancer
- Arthritis
- Chronic Pain
- Parkinson's Disease
- Epilepsy
- Others
Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- BOL Pharma
- Tilray
- Medreleaf Corporation
- Aurora Cannabis Inc.
- Canopy Growth Corporation
- Insys Therapeutics Inc.
- Aphria Inc.
- MGC Pharmaceuticals Limited
- GW Pharmaceuticals plc.
- Medical Marijuana Inc
- Enveric Biosciences
- Pascal Biosciences
- Realize Therapeutics
- Celadon Pharmaceuticals Plc.
- MAK Scientific LLC
- MIRA Pharmaceuticals
- Cardiol Therapeutics

1. Research Objectives and Assumptions

Research Objectives
Assumptions

2. Market Overview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Compound
- Market Snapshot, By Application
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Market Scenario - Conservative, Likely, Opportunistic
Market Opportunity Map

3. Key Insights

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Pest Analysis
Porters Analysis
Technological Advancements
Merger, Acquisition and Collaboration Scenario
Recent Product Approvals
Company Market Share Analysis
Regulatory Scenario
Pricing Analysis
COVID-19 Impact Analysis

4. Global Medicinal Cannabis Market, By Product Type, 2019 - 2031 (US$ Billion)

Introduction
- Market Share (%) Analysis, 2024, 2027 & 2031
- Market Y-o-Y Growth Comparison (%), 2020 - 2031
- Segment Trends
Flower, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Concentrates, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Edibles, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Topicals & Transdermals, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Others, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)

5. Global Medicinal Cannabis Market, By Compound, 2019 - 2031 (US$ Billion)

Introduction
- Market Share (%) Analysis, 2024, 2027 & 2031
- Market Y-o-Y Growth Comparison (%), 2020 - 2031
- Segment Trends
Tetrahydrocannabinol (THC), 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Cannabidiol (CBD), 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)

6. Global Medicinal Cannabis Market, By Application, 2019 - 2031 (US$ Billion)

Introduction
- Market Share (%) Analysis, 2024, 2027 & 2031
- Market Y-o-Y Growth Comparison (%), 2020 - 2031
- Segment Trends
Cancer, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Arthritis, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Chronic Pain, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Parkinson's Disease, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Epilepsy, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Others, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)

7. Global Medicinal Cannabis Market, By Distribution Channel, 2019 - 2031 (US$ Billion)

Introduction
- Market Share (%) Analysis, 2024, 2027 & 2031
- Market Y-o-Y Growth Comparison (%), 2020 - 2031
- Segment Trends
Hospital Pharmacies, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Retail Pharmacies, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Online Pharmacies, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)

8. Global Medicinal Cannabis Market, By Region, 2019 - 2031 (US$ Billion)

Introduction
- Market Share (%) Analysis, 2024, 2027 & 2031, (US$ Billion)
- Market Y-o-Y Growth Comparison (%), 2024 - 2031, (US$ Billion)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Product Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Compound, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Application, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
U.S.
Canada
Europe
- Introduction
- Market Size and Forecast, By Product Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Compound, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Application, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
U.K.
Germany
Italy
France
Spain
Russia
Rest Of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Product Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Compound, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Application, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
China
India
Japan
Australia
South Korea
Asean
Rest Of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, By Product Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Compound, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Application, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
Brazil
Mexico
Argentina
Middle East
- Introduction
- Market Size and Forecast, By Product Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Compound, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Application, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
GCC
Israel
Rest Of The Middle East
Africa
- Introduction
- Market Size and Forecast, By Product Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Compound, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Application, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country/Region, 2019 - 2031, (US$ Billion)
South Africa
North Africa
Central Africa

9. Competitive Landscape

Competitive Snapshot
What Market Participants are Saying?
Competitive Dashboard
Company Market Share Analysis, 2024 - Global

10. Company Profiles - Global Medicinal Cannabis Market

BOL Pharma*
- Company Overview
- Product/Service Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategic Overview
Tilray
Medreleaf Corporation
Aurora Cannabis Inc.
Canopy Growth Corporation
Insys Therapeutics Inc.
Aphria Inc.
MGC Pharmaceuticals Limited
GW Pharmaceuticals plc.
Medical Marijuana Inc
Enveric Biosciences
Pascal Biosciences
Realize Therapeutics
Celadon Pharmaceuticals Plc.
MAK Scientific LLC
MIRA Pharmaceuticals
Cardiol Therapeutics

11. Wheel of Fortune

Wheel of Fortune
Analyst View
Coherent Opportunity Map

12. References and Research Methodology

References
Research Methodology
About us and Sales Contact

02-2729-4219

+886-2-2729-4219

License/价格

医用大麻市场，按产品类型、按化合物、按应用、按分销管道、按地区